Prolonged EVLP Using OCS Lung: Cellular and Acellular Perfusates

Gabriel Loor, Brian T. Howard, John R. Spratt, Lars M. Mattison, Angela Panoskaltsis-Mortari, Roland Z. Brown, Tinen L. Iles, Carolyn M. Meyer, Haylie R. Helms, Andrew Price, Paul A. Iaizzo

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


Background We report the ability to extend lung preservation up to 24 hours (24H) by using autologous whole donor blood circulating within an ex vivo lung perfusion (EVLP) system. This approach facilitates donor lung reconditioning in a model of extended normothermic EVLP. We analyzed comparative responses to cellular and acellular perfusates to identify these benefits. Methods Twelve pairs of swine lungs were retrieved after cardiac arrest and studied for 24H on the Organ Care System (OCS) Lung EVLP platform. Three groups (n = 4 each) were differentiated by perfusate: (1) isolated red blood cells (RBCs) (current clinical standard for OCS); (2) whole blood (WB); and (3) acellular buffered dextran-albumin solution (analogous to STEEN solution). Results Only the RBC and WB groups met clinical standards for transplantation at 8 hours; our primary analysis at 24H focused on perfusion with WB versus RBC. The WB perfusate was superior (vs RBC) for maintaining stability of all monitored parameters, including the following mean 24H measures: Pulmonary artery pressure (6.8 vs 9.0 mm Hg), reservoir volume replacement (85 vs 1607 mL), and PaO2:FiO2 ratio (541 vs 223). Acellular perfusion was limited to 6 hours on the OCS system due to prohibitively high vascular resistance, edema, and worsening compliance. Conclusions The use of an autologous whole donor blood perfusate allowed 24H of preservation without functional deterioration and was superior to both RBC and buffered dextran-albumin solution for extended lung preservation in a swine model using OCS Lung. This finding represents a potentially significant advance in donor lung preservation and reconditioning.

Original languageEnglish (US)
Pages (from-to)2303-2311
Number of pages9
Issue number10
StatePublished - Oct 1 2017

Bibliographical note

Publisher Copyright:
© 2017 Wolters Kluwer Health, Inc.


Dive into the research topics of 'Prolonged EVLP Using OCS Lung: Cellular and Acellular Perfusates'. Together they form a unique fingerprint.

Cite this